Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS

NCT02446886 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Multiple Sclerosis

Interventions

DRUG: Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]